Sadly the pattern of managements incompetence puts them in a bio category of the chronic failure bio class. Lets put it this way...there are management teams that do everything they can to get approval...and then their are management teams that do everything to get a steady paycheck and milk shareholders. Keep in mind IGXT is simply putting an already approved migraine drug on a film....and yet they have failed due to manufacturing deficiencies twice...it's pathetic to say the least...so even with approval it's likely that same incompetence will hamper any real chance at profits...
News 
Market Data 
Discover 
